AstraZeneca Pharma India has partnered with Vaayu Chest & Sleep Center to elevate the standard of respiratory care for severe asthma patients in Bengaluru.

Severe asthma poses a significant challenge as a prevalent non-communicable disease in India, contributing to premature morbidity and mortality. Recent data indicates that approximately 22 lakhs of individuals in Karnataka are grappling with asthma, placing the state seventh in terms of asthmatic population in India.

The Centers of Excellence (CoEs) for severe asthma, aligned with the Global Initiative for Asthma (GINA) guidelines, are designed to offer a systematic and uniform approach to managing patients with severe asthma.

Since the start of this year, AstraZeneca's Severe Asthma COEs have screened over 3000 patients nationwide, accurately assessing disease severity and providing tailored treatment through skilled healthcare professionals engaged in AstraZeneca's educational initiatives.

The company aims to establish 20 clinics across India by the end of 2024, anticipating to screen over 10,000 CoE patients.

At Vaayu’s Severe Asthma Clinic, focus is on holistic asthma management with expert team of doctors for both, adult and pediatric patients, point-of-care advanced testing such as lung capacity test, airway inflammation and allergy testing, integrated pulmonary wellness and rehabilitation services, preventive clinics such as adult vaccination services, smoking cessation and comprehensive sleep clinic, and access to advanced treatment modalities such as high-end injections and procedures.

The collaboration between AstraZeneca and healthcare professionals in the fight against severe asthma has been instrumental in bridging the knowledge gap and providing integrated respiratory care.